JAZZ · CUSIP G50871105
JAZZ PHARMACEUTICALS PLC
Reported by 2 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-08-24.
- Managers holding
- 2
- Average portfolio weight
- 0.6%
- Combined reported value
- $14.9M
- Research group
- 79
2 of the 79 superinvestors Shameless Cloning tracks reported JAZZ PHARMACEUTICALS PLC (JAZZ) in their Q2 2026 13F filings, worth $14.9M combined, at an average 0.6% of their portfolios. The largest positions by portfolio weight belong to Tweedy Browne (1.1%), Polen Capital Management (0.0%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Tweedy BrowneTweedy, Browne Co LLC | 1.1% | $14.5M |
| Polen Capital ManagementPOLEN CAPITAL MANAGEMENT LLC | 0.0% | $448K |